As we navigate through April 2026, the global healthcare landscape stands at a transformative precipice. Artificial Intelligence has evolved from a background diagnostic tool to an active participant in clinical decision-making, even taking the reins of automated drug prescriptions. Yet, a profound question raised by recent discourse in The Washington Post highlights a growing legal vacuum: Can AI be sued? As algorithms begin to sign off on life-altering medications, the legal frameworks of the 20th century are struggling to contain the complexities of 21st-century code.

The Ghost in the Legal Machine

Under current jurisprudence, AI lacks 'legal personhood.' It cannot hold assets, feel remorse, or be held liable in a traditional courtroom. When an AI system suggests a lethal dosage or fails to flag a critical drug interaction, the legal battleground splits into three chaotic fronts: the physician, the software developer, and the healthcare institution. The core of the issue lies in the 'Black Box' problem. If a doctor follows an AI recommendation, they are legally exercising their professional judgment. However, if the AI's logic is so convoluted that no human can truly verify it, that 'judgment' becomes a hollow formality, a mere rubber-stamping of a process the doctor doesn't fully grasp.

  • Product Liability vs. Malpractice: Tech firms argue their AI is a tool, not a practitioner, shielding them behind software licensing agreements.
  • The Accountability Gap: Patients find themselves in a 'no-man's-land' where the doctor blames the tool and the tool's maker blames the user.
  • Automation Bias: The psychological tendency for humans to over-trust automated systems, leading to a decline in critical oversight.

The Jurisdictional Divide: US vs. EU

In 2026, we are witnessing a significant divergence in how the world handles algorithmic errors. The European Union, through the full implementation of the AI Act, treats medical AI as 'high-risk,' demanding rigorous transparency and human-in-the-loop requirements. In the United States, the legal system still leans heavily on the 'Learned Intermediary Doctrine.' This principle suggests that the manufacturer is not liable if they provide adequate warnings to the physician, who acts as the gatekeeper. But this doctrine is fraying. When an AI processes genomic data, lifestyle metrics, and real-time sensor inputs to calibrate a dosage, the physician is no longer a gatekeeper; they are a passenger on a high-speed digital train they cannot steer.

"We are treating 21st-century intelligence with 19th-century liability laws. The machine isn't the one who will stand in court, but the human shield we've placed in front of it is starting to crack," notes a leading legal analyst.

Redefining Responsibility in the Age of Algorithms

The promise of automated prescriptions is undeniable: the elimination of fatigue-related errors and the instant integration of the latest pharmacological research. However, the cost of this efficiency is a fundamental shift in the nature of medical responsibility. To bridge the gap, legal experts are proposing 'Algorithmic Malpractice Insurance' and the creation of federal compensation funds for AI-induced injuries, similar to vaccine injury programs. Furthermore, 'Explainable AI' (XAI) must become a mandatory standard, not a luxury. If a system cannot explain *why* it prescribed a specific drug, it should not have the authority to do so. In the end, AI may never be 'sued' in the way a person is, but the corporations profiting from its deployment must not be allowed to hide behind the complexity of their own creations.